Marketing - Press Releases

Date	Title	Company
04-Apr-2022	CPHI North America opens as 65% of US companies forecast growth in excess of 20% in 2022	CPHI North America
25-Mar-2022	Tiziana Announces Initiation of Phase 1b Clinical Trial in Crohn’s Disease Patients to Evaluate Oral Capsules of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody	Tiziana Life Sciences Ltd
25-Mar-2022	Envirotainer’s Releye® RAP container already approved by 10 airlines	Envirotainer
21-Mar-2022	Creative Enzymes Probiotics Expands Service Offering with the Launch of Lactobacillus Strains	Creative Enzymes
10-Mar-2022	konectar Social - connect with right DOLs	Aissel Technologies Inc
08-Mar-2022	Rapid Microbial Methods, Contamination Control, Sterility Assurance and Environmental Monitoring to be covered at Microbiology East Coast Conference in Boston	SMi Group
05-Mar-2022	Exclusive Chemaxon Interview released - Sponsor at AI in Drug Discovery Conference 2022	SMi Group
23-Feb-2022	New Phase 2b Data Show the Majority of Adults with Moderately to Severely Active Ulcerative Colitis Achieved Clinical Response with TREMFYA®▼ (guselkumab) at 12 Weeks	Janssen
23-Feb-2022	Results of Novel Clinical Study Show Adults with Moderately to Severely Active Ulcerative Colitis Achieved Higher Rates of Clinical Response, Clinical Remission, and Endoscopic Improvement at 12 Weeks with Guselkumab▼ and Golimumab Combination Therapy Versus Either Monotherapy Alone	Janssen
23-Feb-2022	The Majority of Adults with Moderately to Severely Active Crohn’s Disease in a Phase 2 Study Achieved Clinical Remission and Corticosteroid-Free Remission Through 48 Weeks with TREMFYA®▼ (guselkumab)	Janssen
22-Feb-2022	Europe’s Only Parallel Trade Conference returns for its 16th Year	SMi Group
09-Feb-2022	Book to attend the Parallel Trade conference before seats are filled	SMi Group
03-Feb-2022	PENTAX Medical Europe launches premium solution PlasmaTYPHOON+	PENTAX Medical Europe
30-Jan-2022	Darren Green, GSK, conference chair invitation to attend 3rd Annual AI in Drug Discovery Conference	SMi Group
29-Jan-2022	Registration is open for SMi’s 22nd Annual Pain Therapeutics Conference	SMi Group
28-Jan-2022	3D Cell Culture Conference takes place in less than 2 weeks as a virtual conference	SMi Group
26-Jan-2022	RAIN Group Releases New Guide “36 Powerful Sales Questions for Life Sciences”	RAIN Group
24-Jan-2022	WuXi STA Launches its First Parenteral Formulation Manufacturing Line	WuXi STA
21-Jan-2022	Navigating the challenges and legal landscapes of parallel trade	SMi Group
09-Jan-2022	Registration is open for SMi’s 5th Annual Pharmaceutical Microbiology East Coast 2022	SMi Group